Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03002623
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:03.968256+00:00
Published At
2018-12-21T00:00:00+00:00
Record Updated At
2018-12-21
Results Posted At
2018-12-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Thyroid Neoplasms", "Poorly Differentiated and Undifferentiated Thyroid Cancer", "Differentiated Thyroid Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-12-21"
protocolSection.identificationModule.nctId
"NCT03002623"
protocolSection.identificationModule.officialTitle
"A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-12-21"

Study condition terms

  • Thyroid Neoplasms (protocolSection.conditionsModule.conditions)
  • Poorly Differentiated and Undifferentiated Thyroid Cancer (protocolSection.conditionsModule.conditions)
  • Differentiated Thyroid Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.